Power Law company profile

Kite Pharma

Biotech & Life Sciences · Santa Monica, United States · Founded 2009 · IPO 2014 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$12B

Market cap · 2026

Revenue

$20M

Latest reported FY

Investors

4 investors on Kite Pharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Two River

Riverbank Capital Securities

Alta Partners

Series B+ 1 investor entered at this stage

Arie Belldegrun

Global footprint

Where Kite Pharma has talent and traffic

AI talent share

0.4% of workforce is AI talent
(16 of 4,007 staff)

Core AI20.05%

Other AI140.35%

Non-AI workforce3,99199.6%

Web traffic by country

19K monthly visits
across markets

🇺🇸 United States55.8%

🇮🇳 India11.6%

🇬🇧 United Kingdom10%

🇨🇦 Canada8.9%

🇳🇱 Netherlands7.9%

Top 5 markets shown

Patent intelligence

$176M patent portfolio · 154 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$176M

1.5% of market cap · 11.5× smaller than top peer Ablynx ($2B)

154 active patent families

Where Kite Pharma innovates Molecular biologyCell therapyCell biologyAntigen receptorsAntigen binding

Above peer median on Strategic

Quality vs same-sector peers

Kite Pharma on the five Patsnap quality dimensions

Kite Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Kite Pharma concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Kite Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Kite Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo